Epstein-barr virus-encoded barf1 protein is a decoy receptor for macrophage colony stimulating factor and interferes with macrophage differentiation and activation

Viral Immunology

Volumn 25, Issue 6, 2012, Pages 461-470

  Hoebe, Eveline K ^a   Le Large, Tessa Y S ^a   Tarbouriech, Nicolas ^b   Oosterhoff, Dinja ^a   De Gruijl, Tanja D ^a   Middeldorp, Jaap M ^a   Greijer, Astrid E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; BARF1 PROTEIN; CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD169 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOPOLYSACCHARIDE; OXYGEN; TUMOR NECROSIS FACTOR DECOY RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; MACROPHAGE; MACROPHAGE FUNCTION; MICROENVIRONMENT; MOLECULAR INTERACTION; MORPHOLOGY; PHAGOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PURIFICATION; SITE DIRECTED MUTAGENESIS; WILD TYPE;

CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DNA MUTATIONAL ANALYSIS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MUTANT PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRULENCE FACTORS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 84871051772     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2012.0034     Document Type: Article

References (59)

1. Aderem A, and Underhill DM: Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999;17:593-623. (Pubitemid 29241135)
2. Brooks L, Yao QY, Rickinson AB, and Young LS: Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992;66:2689-2697.
3. Chang ET and Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-1777. (Pubitemid 44664247)
4. Chen X, Liu H, Focia PJ, Shim AH, and He X: Structure of macrophage colony stimulating factor bound to FMS: diverse signaling assemblies of class III receptor tyrosine kinases. Proc Natl Acad Sci USA 2008;105:18267-18272.
5. Chitu V and Stanley ER: Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 2006;18:39-48. (Pubitemid 43049646)
6. Cohen JI and Lekstrom K: Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells. J Virol 1999; 73:7627-7632. (Pubitemid 29383247)
7. Daiter E, Pampfer S, Yeung YG, Barad D, Stanley ER, and Pollard JW: Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab 1992; 74:850-858.
8. Dan Q, Sanchez R, Delgado C, et al.: Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor. Mol Ther 2001;4:427-437. (Pubitemid 33100280)
9. Decaussin G, Sbih-Lammali F, de Turenne-Tessier M, Bouguermouh A, and Ooka T: Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies. Cancer Res 2000;60:5584-5588.
10. Fahraeus R, Fu HL, Ernberg I, et al.: Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988;42:329-338.
11. Fogg DK, Sibon C, Miled C, et al.: A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006;311:83-87. (Pubitemid 43063063)
12. Gallo O, Bianchi S, Giannini A, Gallina E, Libonati GA, and Fini-Storchi O: Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope 1991;101:487-493.
13. Guerreiro-Cacais AO, Li L, Donati D, et al.: Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. J Gen Virol 2004;85:2767-2778. (Pubitemid 39360019)
14. Hamilton JA: CSF-1 and cell cycle control in macrophages. Mol Reprod Dev 1997;46:19-23. (Pubitemid 27021349)
15. Hamilton JA: CSF-1 signal transduction. J Leukoc Biol 1997;62:145-155. (Pubitemid 27380786)
16. Hausen zur A, Brink AA, Craanen ME, Middeldorp JM, Meijer CJ, and van den Brule AJ: Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. Cancer Res 2000;60:2745-2748. (Pubitemid 30318253)
17. Hoa N, Myers MP, Douglass TG, et al.: Molecular mechanisms of paraptosis induction: implications for a non-genetically modified tumor vaccine. PLoS One 2009;4:e4631.
18. Hoebe EK, Hutajulu SH, van Beek J, et al.: Purified hexameric Epstein-Barr virus-encoded BARF1 protein for measuring anti-BARF1 antibody responses in nasopharyngeal carcinoma patients. Clin Vaccine Immunol 2011;18:298-304.
19. Houali K, Wang X, Shimizu Y, et al.: A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma. Clin Cancer Res 2007;13:4993-5000. (Pubitemid 47502063)
20. Hume DA: Macrophages as APC and the dendritic cell myth. J Immunol 2008;181:5829-5835.
21. Hutajulu SH, Hoebe EK, Verkuijlen SA, et al.: Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma. Infect Agent Cancer 2010;5:16.
22. Janowska-Wieczorek A, Belch AR, Jacobs A, et al.: Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood 1991;77:1796-1803.
23. Jayasurya A, Bay BH, Yap WM, and Tan NG: Lymphocytic infiltration in undifferentiated nasopharyngeal cancer. Arch Otolaryngol Head Neck Surg 2000;126:1329-1332.
24. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, and Stehlin JS: Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974;71:4737-4741.
25. Lei H, Ju DW, Yu Y, et al.: Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma. Gene Ther 2000;7:707-713. (Pubitemid 30255776)
26. Li J, Zeng XH, Mo HY, et al.: Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy. PLoS One 2007; 2:e1122.
27. Luo B, Wang Y, Wang XF, et al.: Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J Gastroenterol 2005;11:629-633. (Pubitemid 40220748)
28. MacDonald KP, Rowe V, Bofinger HM, et al.: The colonystimulating factor 1 receptor is expressed on dendritic cells during differentiation and regulates their expansion. J Immunol 2005;175:1399-1405. (Pubitemid 41023039)
29. Martorelli D, Houali K, Caggiari L, et al.: Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy. Int J Cancer 2008; 123:1100-1107.
30. Martorelli D, Muraro E, Merlo A, et al.: Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders. Clin Dev Immunol 2012;2012:931-952.
31. Masterson AJ, Sombroek CC, de Gruijl TD, et al.: MUTZ-3, a human cell line model for the cytokine-induced differentiation of dendritic cells from CD34 + precursors. Blood 2002; 100:701-703. (Pubitemid 34761140)
32. Middeldorp JM, Brink AA, van den Brule AJ, and Meijer CJ: Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. Crit Rev Oncol Hematol 2003;45:1-36. (Pubitemid 35449786)
33. Nichols BA, Bainton DF, and Farquhar MG: Differentiation of monocytes. Origin, nature, and fate of their azurophil granules. J Cell Biol 1971;50:498-515.
34. Novak U, Nice E, Hamilton JA, and Paradiso L: Requirement for Y706 of the murine (or Y708 of the human) CSF-1 receptor for STAT1 activation in response to CSF-1. Oncogene 1996;13:2607-2613. (Pubitemid 27046116)
35. O'Keeffe M, Fancke B, and Hochrein H: The generation of plasmacytoid and conventional dendritic cells with M-CSF. Methods Mol Biol 2010;595:187-193.
36. Ohashi M, Orlova N, Quink C, and Wang F: Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene. J Virol 2011;85: 1330-1339.
37. Onai N, Obata-Onai A, Schmid MA, Ohteki T, Jarrossay D, and Manz MG: Identification of clonogenic common Flt3 + M-CSFR + plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 2007;8: 1207-1216. (Pubitemid 350011759)
38. Pandit J, Bohm A, Jancarik J, Halenbeck R, Koths K, and Kim SH: Three-dimensional structure of dimeric human recombinant macrophage colony-stimulating factor. Science 1992; 258:1358-1362. (Pubitemid 23007788)
39. Peng J, Ding T, Zheng LM, and Shao JY: [Influence of tumorassociated macrophages on progression and prognosis of nasopharyngeal carcinoma]. Ai Zheng 2006;25:1340-1345.
40. Pixley FJ and Stanley ER: CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004;14: 628-638. (Pubitemid 39440612)
41. Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4:71-78. (Pubitemid 38082155)
42. Raab-Traub N: Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-441. (Pubitemid 35370756)
43. Santegoets SJ, Masterson AJ, van der Sluis PC, et al.: A CD34( + ) human cell line model of myeloid dendritic cell differentiation: evidence for a CD14( + )CD11b( + ) Langerhans cell precursor. J Leukoc Biol 2006;80:1337-1344. (Pubitemid 44904972)
44. Santegoets SJ, Schreurs MW, Masterson AJ, et al.: In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunol Immunother 2006;55:1480-1490. (Pubitemid 44327836)
45. Sasmono RT, Ehrnsperger A, Cronau SL, et al.: Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1. J Leukoc Biol 2007;82:111-123. (Pubitemid 47026422)
46. Sasmono RT, Oceandy D, Pollard JW, et al.: A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 2003;101:1155-1163. (Pubitemid 36139391)
47. Savard M and Gosselin J: Epstein-Barr virus immunosuppression of innate immunity mediated by phagocytes. Virus Res 2006;119:134-145. (Pubitemid 43765988)
48. Schmid MA, Kingston D, Boddupalli S, and Manz MG: Instructive cytokine signals in dendritic cell lineage commitment. Immunol Rev 2010;234:32-44.
49. Scholl SM, Lidereau R, de la Rochefordiere RA, et al.: Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study. Breast Cancer Res Treat 1996;39:275-283. (Pubitemid 26278942)
50. Seto E, Yang L, Middeldorp J, et al.: Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol 2005;76: 82-88. (Pubitemid 40446460)
51. Stevens SJ, Verkuijlen SA, Hariwiyanto B, et al.: Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer 2006;119:608-614. (Pubitemid 43955715)
52. Strockbine LD, Cohen JI, Farrah T, et al.: The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol 1998;72:4015-4021. (Pubitemid 28188705)
53. Tarbouriech N, Ooka T, and Burmeister WP. Molecular determinants of the BARF1-HCSF1 interaction. EBV Conference 2008;1027.
54. Tarbouriech N, Ruggiero F, de Turenne-Tessier M, Ooka T, and Burmeister WP: Structure of the Epstein-Barr virus oncogene BARF1. J Mol Biol 2006;359:667-678. (Pubitemid 43767259)
55. Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, and Palefsky JM: Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol 2007;81:5484-5496. (Pubitemid 46846989)
56. Turenne-Tessier de M and Ooka T: Post-translational modifications of Epstein Barr virus BARF1 oncogene-encoded polypeptide. J Gen Virol 2007;88:2656-2661. (Pubitemid 47555017)
57. Williams CC, Trinh H, Tran TV, et al.: Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer. Mol Ther 2001;3:216-224. (Pubitemid 32509824)
58. Young LS and Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-768. (Pubitemid 39331148)
59. Zhang CX, Decaussin G, Daillie J, and Ooka T: Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J Virol 1988;62: 1862-1869.